Glaucoma

1-5 of 5

• 

  RestartResume

  Sustained-Release Drug Delivery for Early-Stage Glaucoma

  RestartResume

  Sustained-Release Drug Delivery for Early-Stage Glaucoma

  The Fundingsland Group: Glaucoma Education

  Sustained-Release Drug Delivery for Early-Stage Glaucoma

  Lorraine M. Provencher, MD; Zarmeena Vendal

  • 

    

    Lorraine M. Provencher, MD

  • 

    

    Zarmeena Vendal

  • 

    

    Inder Paul Singh

  • 

    

    Manjool Shah, MD

  • 

    

    Emily Schehlein, MD

  • 

    

    Swarup Swaminathan, MD

• 

  RestartResume

  Personalized Patient-Centered Glaucoma Management

  RestartResume

  Personalized Patient-Centered Glaucoma Management

  The Fundingsland Group: Glaucoma Education

  Personalized Patient-Centered Glaucoma Management

  Inder Paul Singh; Lorraine M. Provencher, MD

  • 

    

    Inder Paul Singh

  • 

    

    Lorraine M. Provencher, MD

  • 

    

    Zarmeena Vendal, MD

  • 

    

    Manjool Shah, MD

  • 

    

    Emily Schehlein, MD

  • 

    

    Swarup Swaminathan, MD

• 

  RestartResume

  SLT as First-Line Therapy

  RestartResume

  SLT as First-Line Therapy

  The Fundingsland Group: Glaucoma Education

  SLT as First-Line Therapy

  Emily Schehlein, MD; Zarmeena Vendal, MD

  • 

    

    Emily Schehlein, MD

  • 

    

    Zarmeena Vendal, MD

  • 

    

    Lorraine M. Provencher, MD

  • 

    

    Inder Paul Singh

  • 

    

    Manjool Shah, MD

  • 

    

    Swarup Swaminathan, MD

• 

  RestartResume

  Modernizing Diagnosis in Early-Stage Glaucoma

  RestartResume

  Modernizing Diagnosis in Early-Stage Glaucoma

  The Fundingsland Group: Glaucoma Education

  Modernizing Diagnosis in Early-Stage Glaucoma

  Manjool Shah, MD; Inder Paul Singh

  • 

    

    Manjool Shah, MD

  • 

    

    Inder Paul Singh

  • 

    

    Zarmeena Vendal, MD

  • 

    

    Lorraine M. Provencher, MD

  • 

    

    Emily Schehlein, MD

  • 

    

    Swarup Swaminathan, MD

• 

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  CME/CE

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  David S. Friedman, MD, PhD, MPH; Steven J. Gedde, MD

  • 

    

    David S. Friedman, MD, PhD, MPH

  • 

    

    Steven J. Gedde, MD

  • 

    

    W. Daniel Stamer, PhD